title: Optimizing the adeno-associated viral vector system: a brief summary.
abstract: rAAV vectors have emerged as one of the leading gene transfer systems in preclinical and clinical applications. Promising intrinsic features of this vector system are nonpathogenicity, high stability and low immunogenicity. Application of the vector system has been improved by simplifying the production procedure and by expanding the vector platform using alternative serotypes and vectors with artificial capsids (mosaic, hybrid or specifically engineered). The current limitations of the vector system are addressed based on the increasing knowledge on the virus-host interaction by further optimizing the capsid as well as the vector genome.
authors: Ulrich
authors: U
authors: Hacker
authors: Hildegard
authors: H
authors: Büning
mesh_terms: D002213:Capsid / Q000276:immunology; D000229:Dependovirus / Q000235:genetics* / Q000276:immunology; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors / Q000235:genetics* / Q000276:immunology; D006801:Humans; D014161:Transduction, Genetic / Q000379:methods